Long-term prophylaxis, or preventive treatment, with Orladeyo (berotralstat) is well tolerated, and results in sustained reductions in swelling attacks…
Andrea Lobo
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo
The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines Agency, has recommended the approval…
A 46-year-old man developed delayed angioedema following surgery — with his tongue swelling significantly four hours later — that…
Pediatricians in Brazil show, in general, a low level of knowledge of hereditary angioedema (HAE), according to a recent…
The use of long-term preventive treatment among people with hereditary angioedema (HAE) was found to significantly reduce the rate…
A 22-year-old woman with systemic lupus erythematosus (SLE), the most common form of lupus, developed acquired angioedema (AAE),…
Nearly half of hereditary angioedema (HAE) patients in the U.K. are on long-term prophylactic treatment to prevent swelling attacks,…
Hereditary angioedema (HAE) Awareness Day is an annual global event held each May 16 to call attention to the…
A 48-year-old man developed angioedema after taking losartan, a medication commonly used to treat high blood pressure, a U.S.
The use of preventive therapy in hereditary angioedema (HAE) was found to reduce the number of HAE attacks requiring…